Epizyme (EPZM) - NASDAQ
From other sites
Company Description
Epizyme, Inc. operates as a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers. It is engaged in the creation of small molecule histone methyltransferase inhibitors, a new... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States